News for '-dr-n-k-arora'

Doctors want govt to allow 4th booster

Doctors want govt to allow 4th booster

Rediff.com4 Jan 2023

'The protective effect of the vaccine lasts for about nine months to a year.' 'For health workers that period is already over. This is the right time to augment their immunity.'

Experts feel COVID-19 has reached endemic phase

Experts feel COVID-19 has reached endemic phase

Rediff.com30 Oct 2022

According to some experts, there is not much difference in the number of seasonal flu cases and that of COVID-19, even though they stressed that surveillance for newer variants should continue in the off chance of a new lineage of coronavirus catching the country off guard.

Amid concerns over Covishield, India studies adverse events

Amid concerns over Covishield, India studies adverse events

Rediff.com13 Mar 2021

Amid concerns over dangerous side-effects of the Oxford's COVID-19 vaccine, India is evaluating all serious adverse events post-vaccination to determine the causality aspects of Covishield and Covaxin, an expert associated with the process said on Saturday.

Covid vaccination for children likely to start soon: Mandaviya

Covid vaccination for children likely to start soon: Mandaviya

Rediff.com28 Jul 2021

Union Health Minister Mansukh Mandaviya on Tuesday told Bharatiya Janata Party MPs that Covid vaccination for children is likely to start soon, sources said.

India doesn't need to ban int'l flights or impose lockdown: Experts

India doesn't need to ban int'l flights or impose lockdown: Experts

Rediff.com24 Dec 2022

The current Covid situation in India is under control and there are no reasons to panic, said Dr N K Arora, the chairperson of National Technical Advisory Group on Immunization (NTAGI).

Centre advises use of mask in crowded areas amid fresh Covid scare

Centre advises use of mask in crowded areas amid fresh Covid scare

Rediff.com21 Dec 2022

He urged people not to panic and clarified that there was no change in the guidelines for international air travel so far.

3rd Covid wave is here, surge in cases points to it, says expert

3rd Covid wave is here, surge in cases points to it, says expert

Rediff.com4 Jan 2022

In the major Indian cities, the Omicron variant of the coronavirus is accounting for more than 50 per cent of the fresh cases of the infection and the massive surge in the number of cases over the last one week is indicative of a third wave of the pandemic, as is being witnessed in several countries, Dr N K Arora, chairman of the COVID-19 working group of the NTAGI, said on Tuesday.

Vaccination for 12-14 age group likely from March: Govt expert

Vaccination for 12-14 age group likely from March: Govt expert

Rediff.com17 Jan 2022

Of the estimated 7.4 crore (7,40,57,000) population in the 15-18 age bracket, over 3.45 crore have received the first dose of Covaxin so far and their second dose is due in 28 days, he said.

Covaxin has shown good response in kids: Govt panel doc

Covaxin has shown good response in kids: Govt panel doc

Rediff.com27 Dec 2021

He explained, "Children between the age of 12 and 18 years, particularly those in the age group of 15 to 18 years, are very much like adults. Our research within the country also says that almost two-thirds of the deaths below 18 years which occurred due to COVID in India are within this age group. So, this decision was mainly taken to protect the adolescents."

Data not sufficient to decide on Covid booster dose: Experts

Data not sufficient to decide on Covid booster dose: Experts

Rediff.com24 Aug 2021

Not enough data has been generated locally to decide on the need for a booster dose of COVID-19 vaccine for those fully inoculated, say experts amid the possibility of a third wave of the viral disease hitting the country between September and October.

Vaccine for children over 12 yrs likely by Aug: NTAGI chief

Vaccine for children over 12 yrs likely by Aug: NTAGI chief

Rediff.com27 Jun 2021

Zydus Cadila COVID-19 vaccine for children above 12 years is expected to be available by August as its trials are likely to be completed by July-end, said Dr N K Arora, Chairman, National Technical Advisory Group on Immunisation (NTAGI).

'No data to show Covid will affect kids in next wave'

'No data to show Covid will affect kids in next wave'

Rediff.com25 May 2021

Arora, who is Director of INCLEN Trust, said it is not possible to predict any third wave at this time.

Tackle rural spread of Covid strategically: Experts

Tackle rural spread of Covid strategically: Experts

Rediff.com24 May 2021

Experts emphasise on the need to curb the spread of the novel coronavirus using strategic and pragmatic approaches in villages as well as Tier 2 and Tier 3 cities and towns, which are reporting increased COVID-19 infections and deaths during the ongoing second wave of COVID-19 pandemic.

Delta plus has more affinity for lung tissues: NTAGI chief

Delta plus has more affinity for lung tissues: NTAGI chief

Rediff.com27 Jun 2021

The Delta plus variant of COVID-19 has greater affinity to lung tissues as compared to other strains but it does not mean that it will cause severe disease or is more transmissible, head of coronavirus working group National Technical Advisory Group on Immunisation (NTAGI) Dr N K Arora said.

Future Covid waves unlikely to have serious impact in India: Experts

Future Covid waves unlikely to have serious impact in India: Experts

Rediff.com20 Mar 2022

The reason is that because of the hybrid immunity after three waves of natural infection and a large proportion of adults receiving both doses of COVID-19 vaccine, the susceptible pool has come down drastically, Lahariya said.

'Untenable': India's top health experts on WHO report on Covid deaths

'Untenable': India's top health experts on WHO report on Covid deaths

Rediff.com6 May 2022

These kinds of assumptions to be used for a nation of India's size and "to put us in poor light is not desirable"

Covid variants, laxity behind India's 2nd wave: Experts

Covid variants, laxity behind India's 2nd wave: Experts

Rediff.com7 Apr 2021

Slack in following COVID appropriate behaviour, a susceptible population and spread of variants could be among the main reasons for the second wave of coronavirus

Govt extends gap between 2 doses of Covishield to 12-18 weeks

Govt extends gap between 2 doses of Covishield to 12-18 weeks

Rediff.com13 May 2021

The NTAGI has also stated that those having laboratory test proven SARS-CoV-2 illness should defer COVID-19 vaccination for six months after recovery, the sources said.

Should Children Get COVID-19 Vaccine?

Should Children Get COVID-19 Vaccine?

Rediff.com8 Sep 2021

Only half India's population has received the first shot of Covishield and Covaxin and the government's immediate task is to first vaccinate its adult population before placing its focus on children.